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As alternatives to human embryonic stem cells (hESCs), such
as induced pluripotent stem cells (hiPSCs) (Park et al., 2008;
Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu
et al., 2007) are explored, an accurate definition of what
constitutes pluripotency becomes important. Continued prog-
ress toward realizing the potential of human pluripotent stem
cells will be facilitated by robust datasets and complementary
resources that are easily accessed and interrogated by the
stem cell community. Many genome-wide microarray expres-
sion studies have been performed on hESCs using a variety of
different technologies (Bock et al., 2011; Chin et al., 2009; Liu
et al., 2006; Muller et al., 2011; Rao et al., 2004; Skottman
et al., 2005; Sperger et al., 2003 and reviewed in Bhattacharya
et al., 2009). To complement the existing data, we report
here the establishment of the Human Pluripotent Stem
Cell Database at the National Institutes of Health (NIH),
StemCellDB, where we provide an in-house dataset of
pluripotent human stem cells. StemCellDB provides data on
all twenty one hESC lines available on the pre-2008 NIH Human
Pluripotent Stem Cell Registry and eight human induced
pluripotent stem cells (iPSCs), derived in-house by retroviral
transduction of human fibroblasts. To facilitate comparisons
of gene expression data between human pluripotent stem
cells for the casual user, in both the undifferentiated and
differentiated states, we have created a user-friendly search
engine. This may be accessed directly at http://stemcelldb.
nih.gov or through the ‘Searchable Databases’ link on the
NIH Stem Cell Unit homepage, http://stemcells.nih.gov/
research/nihresearch/scunit/. Here, a single gene portal
allows users to examine individual genes for expression
under all culture conditions.
To demonstrate the value of the database, we have
compared the microarray gene expression profiles from
undifferentiated and differentiated hESCs, as well as
from 20 adult tissues and provide a list of 169 gene
probes which can be used to define pluripotency at the
gene expression level. Although overall gene expression is
similar in the hESC lines, reproducible differences in
expression between certain genes are observed. In addition
to gene expression microarray data, StemCellDB provides
access to data for single nucleotide polymorphism (SNP)
genotyping, array-based comparative genomic hybridiza-
tion (aCGH), miRNA array and DNA methylation analysis
from matched samples (http://stemcelldb.nih.gov). The
data may also be accessed through the NCBI GEO public
database (Superseries number GSE34200). This facilitates
interrogation and comparison of transcriptional regulation
to advance our understanding of the pluripotent state.
Taken together, the data deposited in StemCellDB consti-
tute a benchmark reference data set which should be of
great interest to the scientific community.Materials and methods
Human ES cell culture
All culture reagents were acquired from Invitrogen unless
stated otherwise. Standard culture conditions of 37 °C, 5%CO2 and 95% humidity were maintained for all cells. Cell
lines used and their suppliers are listed in Table 1.
Human ES cells (hESCs) were cultured on a feeder-layer
of irradiated CF1 mouse embryonic fibroblasts (MEFs) in
DMEM:F12(Cat# 11330–032) containing 20% Knockout
Serum Replacement (KSR) (Cat# 10828–028), 1 mM gluta-
mine (Cat# 25030–081), 0.1 mM β-mercaptoethanol (β-ME;
Sigma), 1× non-essential amino acids (NEAA; Cat#
11140–050) and 4 ng/ml bFGF (R&D Systems) (Cat#
233-FB). Fibroblasts were cultured in DMEM (Cat#
11965–092) containing 10% fetal bovine serum (FBS)
(Gemini Bio-products), 2 mM glutamine and 1× NEAA.
Fibroblasts were irradiated with ~6500 rads using a
Faxitron RX650 X-irradiator. They were subsequently
plated on Falcon 6-well tissue culture dishes, coated with
0.1% gelatin, at a density of 0.1875×106/well. hESCs were
plated in small clumps the following day, medium was
exchanged every day and colonies were passaged by
collagenase treatment every 3–4 days. Briefly, cultures
were treated with 1.5 mg/ml collagenase IV for 20–40 min
and either tapped sharply or scraped to dislodge colonies.
Colonies were allowed to sediment for 5 min, the superna-
tant was removed and fresh media added. This process was
repeated for a total of 3 sediments. At this point cells were
triturated to generate colonies of approximately 10–100
cells for passaging or 50–250 cells for embryoid body (EB)
formation. Embryoid bodies were cultured in fibroblast
medium (FBS; EB_mesend) or in hESC mediumwithout bFGF
(EB_ecto) in 60 mm Corning Low Attachment dishes for a
total of 8 days. Media were changed by sedimentation
every 2 days. An important point to note is that the same
lot number of FBS was used for all studies.
Nucleic acid extractions
For Comparative Genomic Hybridization (CGH), genomic
DNA was extracted using the Wizard Genomic DNA
Purification Kit (Promega) according to the manufacturer's
instructions.
For gene expression microarray analysis, RNA was
extracted using a modification of the basic Trizol
(Invitrogen) protocol. Briefly, 1 ml of Trizol was added to
sedimented colonies or EBs and triturated to dissociate the
cells. At this point the lysates were stored at −80 °C until
all samples for that cell line were collected. Upon thaw,
lysates were incubated at room temperature for 10 min,
mixed with 200 μl chloroform and centrifuged in a
Phase-Lock Gel (heavy) Eppendorf tube (Qiagen). RNA
was precipitated from the aqueous phase by the addition of
250 μl of isopropanol and 250 μl of a high salt buffer (0.8 M
sodium citrate and 1.2 M NaCl) followed by centrifugation.
The RNA pellet was washed twice with 75% ethanol, dried
and resuspended in nuclease-free water. RNA was DNase
treated for 20 min and the DNase removed using Ambion's
DNA-Free kit. Concentration was determined using a
NanoDrop ND-1000 UV–VIS spectrophotometer.
Array technologies
Global gene expression analysis was performed using Agilent
human One Color Gene Expression Oligo arrays, reagents
Table 1 Karyotype and FISH analysis for chromosomes 12 and 17 are provided where performed (ND — not done). Both NIH and
supplier nomenclature are given for all hESCs. The Coriell reference number is given for the hiPSC lines generated from that source
cell line.
Cell line Supplier name Supplier Passage # Karyotype Chr 12&17 fish
BG01 hESBGN-01 BresaGen, Inc 79 Normal Normal
BG02 hESBGN-02 BresaGen, Inc 54 Normal Normal
BG03 hESBGN-03 BresaGen, Inc ND ND ND
ES01 HES-1 ES Cell International 72 Normal ND
ES02 HES-2 ES Cell International 49 Normal Normal
ES03 HES-3 ES Cell International 88 Normal Normal
ES04 HES-4 ES Cell International 76 Normal Normal
ES05 HES-5 ES Cell International 59 Normal Normal
ES06 HES-6 ES Cell International 62 Normal Normal
SA01 Sahlgrenska-1 Cellartis AB 32 Normal Normal
SA02 Sahlgrenska-2 Cellartis AB 39 Abnormal a Normal
TE03 I3 Technion — Israel Institute of Technology 70 Normal Normal
TE04 I4 Technion — Israel Institute of Technology ND ND ND
TE06 I6 Technion — Israel Institute of Technology 64 Abnormal b Normal
UC01 HSF-1 University of California, San Francisco 64 Normal 1/200 trisomy 12
UC06 HSF-6 University of California, San Francisco 59 Normal Normal
UC06 HSF-6 University of California, San Francisco 114 Normal Normal
WA01 H1 WiCell Research Institute 57 Normal Normal
WA07 H7 WiCell Research Institute 54 Normal 2/200 trisomy 17
WA09 H9 WiCell Research Institute 45 Normal Normal
WA13 H13 WiCell Research Institute ND ND ND
WA14 H14 WiCell Research Institute 40 Normal ND
NIH-i1 Neonatal HFF NIH/Vogel Lab 16 Normal Normal
NIH-i2 AG20443 Coriell 24 Normal Normal
NIH-i4 AG20443 Coriell 21 Abnormal c Normal
NIH-i5 AG20443 Coriell 21 Normal Normal
NIH-i7 AG08395 Coriell 21 Normal Normal
NIH-i11 AG20443 Coriell 25 Abnormal c Normal
NIH-i12 AG08396 Coriell 21 Normal Normal
NIH-i13 AG08396 Coriell 18 Normal Normal
a Trisomy 13 characteristic of this line.
b Nonclonal aberrations in 2/20.
c Balanced translocation present in the parent fibroblasts.
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Comparative genomic hybridization and analysis was performed
using Agilent software, reagents and arrays according to the
manufacturer's instructions using 3 μg genomic DNA. Control
male and female DNA was obtained from Promega. SNP
analysis and methylation profiling were conducted by AGTC,
Fairfax, VA using the Illumina Human1M-Duov3 and Human
Methylation 27 k platforms respectively. MicroRNA arrays
were performed using Agilent Human miRNA microarray kits,
reagents and software.Microarray data statistical analysis
The statistical programming language R (http://cran.r-
project.org/) was used. Details are also shown in Supplemen-
tal Fig. 1. Raw expression measurements for all gene probes
for all samples were log (base=2) transformed then quantilenormalized. Quality of data was assured via sample-level
inspection by Tukey box plot, covariance-based PCA scatter
plot and correlation-based Heat Map. Raw expression mea-
surements for samples deemed outliers were discarded and
quantile normalization repeated. Gene probes not having at
least one expression measurement greater than system
noise post normalization were deemed “noise-biased” and
discarded. System noise was defined as the lowest observed
expression measurement at which the LOWESS (locally
weighted scatterplot smoothing) fit of the CV (coefficient of
variation) by mean for each gene probe for each class of
samples (i.e., “ES undiff”, “ES EB_ecto”, “ES EB_mesend”)
grossly deviates from linearity. For gene probes not discarded,
expression measurements were floored to equal system noise
if less than system noise and were then subject to the
one-factor ANOVA (analysis of variance) under BH (Benjamini
and Hochberg) FDR (false discovery rate) MCC (multiple
comparison correction) condition. Gene probes with a
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Figure 1 (A) Covariance PCA scatterplot and (B) Pearson correlation heat map depicting 175 samples using log (base=2)
transformed quantile normalized expression for 4482 gene probes per sample. Gene probes selected for use represent those not
noise-biased, not processing-biased, not gender-biased that pass ANOVA under multiple comparison correction condition (Pb0.05)
using class as the factor, pass post-hoc testing for at least one pair-wise class comparison (Tukey HSD Pb0.05) and pass a mean–
difference criteria (≥1.75) for the same pair-wise class comparison having a Tukey HSD Pb0.05.
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tive” and subject to the TukeyHSD (honestly significant
difference) post-hoc test. Gene probes having a post-hoc
P-value b0.05 and a difference of class means ≥1.50 for a
specific comparison of classes were deemed to have expres-
sion “significantly different” between the two classes. For
these gene probes, measurements were subsequently inter-
rogated for association with processing time and/or differ-
ences in gender using PolySerial correlation and ANOVA
respectively under BH FDR MCC condition (alphab0.05).
Those gene probes having measurements significantly associ-
ated with processing time were deemed “processing-biased”
while gene probes having measurements significantly associ-
ated with differences in gender were deemed “gender-biased”. Annotations and associated functions for each gene
probe were obtained using IPA (Ingenuity, Inc.).Results and discussion
Comparison of hESCs and hiPSCs gene expression
profiles
All twenty one hESC lines available on the pre-2008 NIH Human
Pluripotent Stem Cell Registry and eight human iPSCs, derived
in-house by retroviral transduction of human fibroblasts were
adapted to one standard culture protocol. The cells were
expanded to assess their identity and genomic integrity. Short
Table 2 Putative markers of pluripotency. Of the original 489 gene probes down-regulated in both differentiation conditions,
169 were found to be expressed in somatic tissues at a level less than the 5th percentile observed in hESCs and are designated
markers of pluripotency.
GeneProbe Gene Gene_description
A_32_P74847 LARP7 La ribonucleoprotein domain family, member 7
A_24_P668974 LARP7 La ribonucleoprotein domain family, member 7
A_24_P383640 POU5F1P3 POU class 5 homeobox 1 pseudogene 3
A_32_P211752 LOC100506507 Hypothetical LOC100506507
A_32_P132563 POU5F1 POU class 5 homeobox 1
A_24_P144601 POU5F1 POU class 5 homeobox 1
A_24_P214841 POU5F1 POU class 5 homeobox 1
A_23_P327910 ZIC3 Zic family member 3
A_23_P140362 VRTN Vertebrae development homolog (pig)
A_23_P204640 NANOG Nanog homeobox
A_23_P25587 LECT1 Leukocyte cell derived chemotaxin 1
A_23_P329798 CER1 Cerberus 1, cysteine knot superfamily, homolog (Xenopus laevis)
A_23_P59138 POU5F1 POU class 5 homeobox 1
A_23_P72817 GDF3 Growth differentiation factor 3
A_23_P380526 DPPA4 Developmental pluripotency associated 4
A_32_P135985 TDGF1 Teratocarcinoma-derived growth factor 1
A_23_P127322 NODAL Nodal homolog (mouse)
A_23_P137484 L1TD1 LINE-1 type transposase domain containing 1
A_23_P374844 GAL Galanin prepropeptide
A_23_P366376 TDGF1 Teratocarcinoma-derived growth factor 1
A_23_P216149 TERF1 Telomeric repeat binding factor (NIMA-interacting) 1
A_24_P357266 GRPR Gastrin-releasing peptide receptor
A_32_P220696 TERF1 Telomeric repeat binding factor (NIMA-interacting) 1
A_23_P137573 LEFTY2 Left–right determination factor 2
A_24_P90022 SEPHS1 Selenophosphate synthetase 1
A_24_P192434 TERF1 Telomeric repeat binding factor (NIMA-interacting) 1
A_23_P207999 PMAIP1 Phorbol-12-myristate-13-acetate-induced protein 1
A_23_P102471 MSH2 MutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)
A_24_P392475 BPTF Bromodomain PHD finger transcription factor
A_23_P28153 SCLY Selenocysteine lyase
A_23_P209337 METTL21A Methyltransferase like 21A
A_24_P50458 TERF1 Telomeric repeat binding factor (NIMA-interacting) 1
A_23_P204246 PHC1 Polyhomeotic homolog 1 (Drosophila)
A_23_P156310 SKP2 (includes
EG:27401)
S-phase kinase-associated protein 2 (p45)
A_32_P137926 MMS22L MMS22-like, DNA repair protein
A_23_P14821 GABRB3 Gamma-aminobutyric acid (GABA) A receptor, beta 3
A_32_P87531 DNAH14 Dynein, axonemal, heavy chain 14
A_23_P256142 AKIRIN1 Akirin 1
A_24_P162929 METTL21A Methyltransferase like 21A
A_32_P741851 GLB1L3 Galactosidase, beta 1-like 3
A_24_P118452 SEPHS1 Selenophosphate synthetase 1
A_23_P47058 CUZD1 CUB and zona pellucida-like domains 1
A_24_P655268 LOC729082 Hypothetical LOC729082
A_24_P916586 BICD1 Bicaudal D homolog 1 (Drosophila)
A_23_P156842 EEF1E1 Eukaryotic translation elongation factor 1 epsilon 1
A_23_P259127 ESRP1 Epithelial splicing regulatory protein 1
A_32_P76091 HSPD1 Heat shock 60 kDa protein 1 (chaperonin)
A_24_P134727 TFAM Transcription factor A, mitochondrial
A_23_P160336 LEFTY1 Left–right determination factor 1
A_24_P244699 NUDT15 Nudix (nucleoside diphosphate linked moiety X)-type motif 15
A_24_P52921 BCAT1 Branched chain amino-acid transaminase 1, cytosolic
A_23_P214907 MTHFD1L Methylenetetrahydrofolate dehydrogenase (NADP+dependent) 1-like
A_32_P213091 SHISA9 Shisa homolog 9 (Xenopus laevis)
A_23_P323094 PHC1 Polyhomeotic homolog 1 (Drosophila)
(continued on next page)
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Table 2 (continued)
GeneProbe Gene Gene_description
A_23_P82823 PINX1 PIN2/TERF1 interacting, telomerase inhibitor 1
A_23_P162256 DENR Density-regulated protein
A_23_P365060 MDN1 MDN1, midasin homolog (yeast)
A_23_P18818 CNOT6 CCR4-NOT transcription complex, subunit 6
A_23_P148484 RLIM Ring finger protein, LIM domain interacting
A_23_P111373 MRS2 (includes
EG:380836)
MRS2 magnesium homeostasis factor homolog (S. cerevisiae)
A_23_P203201 DDX6 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6
A_23_P92410 CASP3 Caspase 3, apoptosis-related cysteine peptidase
A_23_P216118 UNC5D Unc-5 homolog D (C. elegans)
A_23_P214111 KIF13A Kinesin family member 13A
A_23_P138465 NOLC1 Nucleolar and coiled-body phosphoprotein 1
A_23_P121423 CDC25A Cell division cycle 25 homolog A (S. pombe)
A_23_P136504 SLC25A21 Solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21
A_23_P73220 FGD6 FYVE, RhoGEF and PH domain containing 6
A_23_P421436 ADD2 Adducin 2 (beta)
A_23_P23356 RRP15 (includes
EG:327053)
Ribosomal RNA processing 15 homolog (S. cerevisiae)
A_32_P34826 C21orf88 Chromosome 21 open reading frame 88
A_24_P128977 G3BP2 GTPase activating protein (SH3 domain) binding protein 2
A_23_P405761 RRAS2 Related RAS viral (r-ras) oncogene homolog 2
A_23_P70168 TARS Threonyl-tRNA synthetase
A_24_P415260 DDX21 DEAD (Asp-Glu-Ala-Asp) box polypeptide 21
A_24_P253215 EMG1 EMG1 nucleolar protein homolog (S. cerevisiae)
A_23_P54834 NIP7 Nuclear import 7 homolog (S. cerevisiae)
A_23_P155407 RTP1 Receptor (chemosensory) transporter protein 1
A_24_P297888 MTAP Methylthioadenosine phosphorylase
A_23_P351215 SKIL SKI-like oncogene
A_32_P1614 LOC100506054 Hypothetical LOC100506054
A_24_P213794 CCRN4L CCR4 carbon catabolite repression 4-like (S. cerevisiae)
A_23_P10966 GABRB3 Gamma-aminobutyric acid (GABA) A receptor, beta 3
A_23_P160881 SMPDL3B Sphingomyelin phosphodiesterase, acid-like 3B
A_23_P373119 HMG4L High mobility group box 3 pseudogene 1
A_23_P27167 RNASEH1 Ribonuclease H1
A_24_P49747 HMGB3P24 High mobility group box 3 pseudogene 24
A_23_P213908 PHAX Phosphorylated adaptor for RNA export
A_23_P358417 TIMM8A Translocase of inner mitochondrial membrane 8 homolog A (yeast)
A_24_P902052 SNHG13 Small nucleolar RNA host gene 13 (non-protein coding)
A_24_P24685 HMGB3P22 High mobility group box 3 pseudogene 22
A_24_P13533 LRR1 Leucine rich repeat protein 1
A_23_P215484 CCL26 Chemokine (C–C motif) ligand 26
A_23_P252362 MRPS30 Mitochondrial ribosomal protein S30
A_24_P943922 CACHD1 Cache domain containing 1
A_32_P194264 CHAC2 ChaC, cation transport regulator homolog 2 (E. coli)
A_24_P922606 NUP160 Nucleoporin 160 kDa
A_23_P133216 NLN Neurolysin (metallopeptidase M3 family)
A_23_P128991 SLIRP SRA stem-loop interacting RNA binding protein
A_23_P56553 METTL8 Methyltransferase like 8
A_23_P355075 CENPN Centromere protein N
A_23_P134008 USP45 Ubiquitin specific peptidase 45
A_23_P41255 G3BP2 GTPase activating protein (SH3 domain) binding protein 2
A_23_P145724 C7orf16 Chromosome 7 open reading frame 16
A_23_P87759 EMG1 EMG1 nucleolar protein homolog (S. cerevisiae)
A_23_P56865 DDX18 DEAD (Asp-Glu-Ala-Asp) box polypeptide 18
A_24_P134626 TXLNG Taxilin gamma
A_24_P234196 RRM2 Ribonucleotide reductase M2
A_23_P214354 EXOC2 Exocyst complex component 2
A_23_P5370 RPRM Reprimo, TP53 dependent G2 arrest mediator candidate
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Table 2 (continued)
GeneProbe Gene Gene_description
A_24_P12573 CCL26 Chemokine (C–C motif) ligand 26
A_23_P72770 USP44 Ubiquitin specific peptidase 44
A_24_P272389 LOC285216 Methylenetetrahydrofolate dehydrogenase (NADP+dependent) 2,
methenyltetrahydrofolate cyclohydrolase pseudogene
A_23_P54540 EIF2AK4 Eukaryotic translation initiation factor 2 alpha kinase 4
A_24_P347624 SNURF SNRPN upstream reading frame
A_24_P128085 RC3H2 Ring finger and CCCH-type domains 2
A_23_P102183 PNO1 Partner of NOB1 homolog (S. cerevisiae)
A_32_P71788 FKBP4 FK506 binding protein 4, 59 kDa
A_23_P204170 TMPO Thymopoietin
A_32_P44775 C9orf85 Chromosome 9 open reading frame 85
A_23_P143958 RPL22L1 Ribosomal protein L22-like 1
A_24_P914479 SNX5 Sorting nexin 5
A_23_P427217 JMJD1C Jumonji domain containing 1C
A_23_P204380 GNPTAB N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
A_24_P344307 PSME3 Proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
A_24_P100664 MKKS McKusick-Kaufman syndrome
A_23_P218918 FGF2 Fibroblast growth factor 2 (basic)
A_24_P314477 TUBB2B Tubulin, beta 2B
A_24_P15754 TOMM40 Translocase of outer mitochondrial membrane 40 homolog (yeast)
A_23_P37497 MYO1E Myosin IE
A_24_P143843 LOC729566 Zinc finger and BTB domain containing 8 opposite strand pseudogene 1
A_24_P152404 C10orf76 Chromosome 10 open reading frame 76
A_23_P125001 RAC3 Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
A_23_P135063
A_24_P161773
A_24_P178523
A_24_P179646
A_24_P195286
A_24_P221285
A_24_P340659
A_24_P341106
A_24_P341731
A_24_P358302
A_24_P367326
A_24_P392505
A_24_P410000
A_24_P41189
A_24_P455060
A_24_P560332
A_24_P58597
A_24_P67063
A_24_P67681
A_24_P695223
A_24_P707102
A_24_P711050
A_24_P752362
A_24_P76142
A_24_P901084
A_24_P928765
A_32_P104334
A_32_P146320
A_32_P152696
A_32_P157504
A_32_P207147
A_32_P24068
A_32_P63086
(continued on next page)
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Table 2 (continued)
GeneProbe Gene Gene_description
A_32_P65691
A_32_P885123
A_32_P89049
64 B.S. Mallon et al.Tandem Repeat (STR) and single nucleotide polymorphism
(SNP) genotyping confirmed that each line was genetically
unique. Cytogenetic and array comparative genomic hybrid-
ization (aCGH) analysis showed that most cell lines have a
normal chromosome complement (Table 1). In addition, flow
cytometry demonstrated that nearly all cells expressed the
pluripotent markers POU5F1 (Oct-4) and Tra-1-81. Quality
control reports are available on our website, http://
stemcelldb.nih.gov.
Covariance principal component analysis (PCA) and
Pearson correlation of the gene expression microarray data
indicated that hESCs and hiPSCs are grossly similar (class
meansN0.865) in the undifferentiated and differentiated
states (Figs. 1A and B). In no class was any gene found to be
exclusively expressed by one population of pluripotent cell
versus the other. Thus, in agreement with published reports
(Guenther et al., 2010), we conclude by this measure that
there is no absolutely unique gene expression profile that
can be assigned to hESCs or hiPSCs.Pluripotency-associated genes
We assessed the expression and regulation of pluripotency
markers in hESCs only and generated a list of 489 gene
probes which are down-regulated in both differentiationCBA
GFE
Figure 2 A–D) eNorthern of pluripotency genes — A) POU5F1/
differentiation associated gene expression — E) PAX6; F) RAX; G) MY
blue = EB_mesend.conditions (Supplemental Table 1). Of this list, 169 gene
probes were found to be expressed in somatic tissues at a
level less than the 5th percentile observed in hESCs and are
designated markers of pluripotency (Table 2). Included in
this “pluripotency” list are genes involved in maintenance of
the pluripotent state such as POU5F1 and NANOG (Figs. 2A
and B) as well as many components/targets of the
TGFβ-superfamily signaling network including NODAL and
TDGF1 (Figs. 2C and D). This is consistent with a requirement
for Activin/Nodal signaling in the maintenance of hESCs as
described previously (James et al., 2005; Vallier et al.,
2004). Also in the “pluripotency” list are gene probes that
have not been annotated at this time, raising the possibility
of novel pluripotency-associated genes. The use of these 169
probes in a focused array could possibly be used as a
fingerprint for pluripotent stem cells.Differentiation pathways in two embryoid body
culture media
The differentiation conditions selected for embryoid body (EB)
differentiation were designated EB_ecto, for ectodermal
lineage, and EB_mesend, for mesendodermal lineage. We
examined which genes changed under each condition to see if
the differentiation media truly affected fate bias. We foundD
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Figure 3 A) The StemCellDB gene expression search engine. A
casual user can search their gene of interest directly or a
more experienced user can access all raw data deposited with
NCBI GEO by using the GEO Submissions link on the sidebar.
B) Returned search results. Pop-up menus for each probe allow
a user to select the most informative probes for further
examination. C) Data is available in several formats for instant
viewing as a chart or for download.
65StemCellDB: The Human Pluripotent Stem Cell Database at the National Institutes of Health595 gene probes up-regulated in both conditions, 243 gene
probes enriched in the EB_ecto condition, and 1086 gene
probes enriched in the EB_mesend condition (Supplemental
Table 2). Many genes encoding neurectodermal markers, such
as PAX6, RAX (Figs. 2E and F), LHX2, and LMO1, are detected in
the EB_ecto-enriched group, fitting gene ontology analysis
indicating roles for this group in nervous system development
and function. The 1086 genes enriched in the EB_mesend
group include many genes encoding mesendodermal markers,
such asMYH6 and TNNT2 (Figs. 2G and H), as well as manyHOX
and hemoglobin genes. Gene ontology analysis of this group
demonstrates roles in cardiogenesis, vasculogenesis as well as
muscular development. Taken together, the gene probes
found to be up-regulated in EB_ecto or EB_mesend can
discriminate lineage differentiation.
Using the StemCellDB gene expression search engine
The StemCellDB website is designed primarily to facilitate
interrogation of the gene expression information by a
casual user. Upon accessing the site, either directly at
http://stemcelldb.nih.gov or through the ‘Searchable Data-
bases’ link on the NIH Stem Cell Unit homepage http://
stemcells.nih.gov/research/nihresearch/scunit/, an option
to search the Agilent or Affymetrix datasets is presented.
The Affymetrix dataset is a minor subset of the Agilent data
which we have provided for comparison to other datasets
commonly available. Selecting either dataset will not only
present various options to search for a gene of interest for a
casual user but also allows access to all datasets, for an
advanced user, using the GEO submissions link on the sidebar
(Fig. 3A). Upon searching the preferred cell type or tissue
data, multiple probes may be returned as hits, not all of which
may give useful information depending on probe location and
other factors. With the Agilent dataset, a pop-upmenu gives a
snapshot of the data spread for each probe to allow the user to
select the most informative probes for further evaluation
(Fig. 3B). Once a probe is selected, the data is available for
download or for charting. The Agilent dataset providesmedian
normalized data as well as quantile raw-based, quantile
median normalized-based and quantile log2 raw-based data,
which are used for our analysis (Fig. 3C). Using the drop-down
menus, the dataset may be downloaded as PDF, MS-Excel or
text formats and charts plotted according to the desired data
type. A more detailed tutorial for the use of the gene
expression search engine may be found on the navigational
sidebar (Fig. 3C).
We have also provided the quantile log2 gene expression
data for the cell lines as a Microsoft Excel spreadsheet in
Supplemental data (Supplemental Table 3).
Conclusion
Here we report the launch of StemCellDB, a database of
molecular profiles which together provide a comprehen-
sive snapshot of human embryonic stem cells in their
undifferentiated state including general differentiation
potential. As described in other studies, we find no
iPSC-specific gene expression pattern under any of the
three culture conditions. We have analyzed the data to
provide a list of 169 gene probes, which may be used as afingerprint of pluripotency and show that 2 independent
differentiation conditions can upregulate genes associated
with different lineages. We have designed a user-friendly
66 B.S. Mallon et al.search engine to facilitate casual interrogation of the gene
expression data. Together, this provides a useful resource
for the stem cell community.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2012.09.002.
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